pubmed-article:9596235 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9596235 | lifeskim:mentions | umls-concept:C0751956 | lld:lifeskim |
pubmed-article:9596235 | lifeskim:mentions | umls-concept:C0024480 | lld:lifeskim |
pubmed-article:9596235 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:9596235 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:9596235 | lifeskim:mentions | umls-concept:C2698650 | lld:lifeskim |
pubmed-article:9596235 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:9596235 | pubmed:dateCreated | 1998-6-11 | lld:pubmed |
pubmed-article:9596235 | pubmed:abstractText | Parenterally administered MgSO4 is neuroprotective in standard animal models of focal cerebral ischemia and in many other paradigms of brain injury. Previous small clinical trials in stroke patients have explored the safety and tolerability of different infusion regimens. This study was undertaken to optimize the regimen for a multicenter trial. | lld:pubmed |
pubmed-article:9596235 | pubmed:language | eng | lld:pubmed |
pubmed-article:9596235 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9596235 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9596235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9596235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9596235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9596235 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9596235 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9596235 | pubmed:month | May | lld:pubmed |
pubmed-article:9596235 | pubmed:issn | 0039-2499 | lld:pubmed |
pubmed-article:9596235 | pubmed:author | pubmed-author:MuirK WKW | lld:pubmed |
pubmed-article:9596235 | pubmed:author | pubmed-author:LeesK RKR | lld:pubmed |
pubmed-article:9596235 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9596235 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:9596235 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9596235 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9596235 | pubmed:pagination | 918-23 | lld:pubmed |
pubmed-article:9596235 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:meshHeading | pubmed-meshheading:9596235-... | lld:pubmed |
pubmed-article:9596235 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9596235 | pubmed:articleTitle | Dose optimization of intravenous magnesium sulfate after acute stroke. | lld:pubmed |
pubmed-article:9596235 | pubmed:affiliation | University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland. k.muir@clinmed.gk.ac.uk | lld:pubmed |
pubmed-article:9596235 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9596235 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9596235 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:9596235 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9596235 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9596235 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9596235 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9596235 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9596235 | lld:pubmed |